Quality of life as a parameter determining therapeutic choices in cancer care in a Greek sample

Abstract

Health-related quality of life (HRQL) is difficult to define and measure. It is a generic term that includes concepts such as physical health, life satisfaction, psychological well-being and self-integrity. Realizing and appreciating the importance of HRQL is crucial for physicians if they are to be in a position to offer appropriate suggestions in assisting patients and their families in the decision-making process regarding cancer treatment and terminal care. In order to determine whether Greek physicians take into consideration HRQL when assessing different therapeutic options, we conducted a postal survey. A total of 1500 Greek physicians (internists, oncologists and anaesthesiologists) were asked to complete a questionnaire. We received replies from 1280 (85%). In summary, we found that Greek physicians: (1) have already started taking HRQL into consideration when reviewing their therapeutic options; (2) increasingly include HRQL in research studies as an outcome measure; (3) do not yet have thoroughly sufficient training in the holistic care of cancer patients and their families; (4) mostly do not have the opportunity to work in interdisciplinary therapeutic teams where they can exchange ideas and consider different aspects of alternative therapeutic methods.

It is concluded that HRQL has already been introduced as an important determinant of therapeutic choices in cancer care in Greece. However, efforts need to be made to allow HRQL to enjoy its appropriate place in cancer care.

Keywords

attitude of health personnel neoplasms palliative care physician's practice patterns quality of life

Get full access to this article

View all access options for this article.

References

Slevin ML , Stubbs L , Plant HJ et al. Attitudes to chemotherapy: comparing views of patients with cancer with those of doctors, nurses and general public. Br Med J 1990; 300: 1458–1460.

Patrick DL , Pearlman RA , Starks HE , Cain KC , Cole WG , Uhlmann RF . Validation of preferences for life-sustaining treatment: implications for advanced care planning. Ann Intern Med 1997; 127: 509–517.

Coates A , Porzsolt F , Osoba D . Quality of life in oncology practice: prognostic value of EORTC QLQ-C30 scores in patients with advanced malignancy. Eur J Cancer 1997; 33: 1025–1030.

Mystakidou K , Liossi C , Vlachos L , Papadimitriou J . Disclosure of diagnostic information to cancer patients in Greece. Palliat Med 1996; 10: 195–200.

Buckman R . Talking to patients about cancer. BMJ 1996; 313: 699–700.

Simpson M , Buckman R , Stewart M et al. Doctor–patient communication: the Toronto consensus statement. BMJ 1991; 303: 1385–1387.

Meredith C , Symonds P , Webster L et al. Information needs of cancer patients in West Scotland: cross-sectional survey of patients' views. BMJ 1996; 313: 724–726.

Shogren E . Physicians favour death with ‘dignity’. Philadelphia Enquirer 1988; June 3: D14.

Downie RS , Calman KC . Healthy respect. Ethics in health care. Athens: Litsas Medical, 1997.

10.

Groenvold M , Klee MC , Sprangers MA , Aaronson NK . Validation of the EORTC QLQ-C30 quality of life questionnaire through combined qualitative assessment of patient–observer agreement. J Clin Epidemiol 1997; 50: 441–450.

11.

Osoba D , Aaronson N , Zee B , Sprangers M , te-Velde A . Modification of the EORTC QLQ-C30 (version 2.0) based on content validity and reliability testing in large samples of patients with cancer. The Study Group on Quality of Life of the EORTC and the Symptom Control and Quality of Life Committees of the NCI of Canada Clinical Trials Group. Qual Life Res 1997; 6: 103–108.

12.

Maguire P , Faulkner A , Booth K , Elliott C , Hillier V . Helping cancer patients to disclose their concerns. Eur J Cancer 1996; 32: 78–81.